| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Vincent T. DeVita, Jr., Susan Molloy Hubbard, and Dan L. Longo
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
This article has been cited by other articles:
![]() |
M. Federico, S. Luminari, E. Iannitto, G. Polimeno, L. Marcheselli, A. Montanini, A. La Sala, F. Merli, C. Stelitano, S. Pozzi, et al. ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial J. Clin. Oncol., February 10, 2009; 27(5): 805 - 811. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Gobbi, C. Broglia, F. Valentino, C. Mammi, M. Lombardo, F. Merli, S. Luminari, G. Polimeno, A. Riezzo, P. Lambelet, et al. The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL) Ann. Onc., April 1, 2006; 17(4): 676 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Gobbi, C. Broglia, A. Levis, A. La Sala, F. Valentino, T. Chisesi, S. Sacchi, F. Corbella, L. Cavanna, E. Iannitto, et al. MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year Results, Late Toxicity, and Second Tumors Clin. Cancer Res., January 15, 2006; 12(2): 529 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Gobbi, A. Levis, T. Chisesi, C. Broglia, U. Vitolo, C. Stelitano, V. Pavone, L. Cavanna, G. Santini, F. Merli, et al. ABVD Versus Modified Stanford V Versus MOPPEBVCAD With Optional and Limited Radiotherapy in Intermediate- and Advanced-Stage Hodgkin's Lymphoma: Final Results of a Multicenter Randomized Trial by the Intergruppo Italiano Linfomi J. Clin. Oncol., December 20, 2005; 23(36): 9198 - 9207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Federico, M. Bellei, P. Brice, M. Brugiatelli, A. Nagler, C. Gisselbrecht, L. Moretti, P. Colombat, S. Luminari, F. Fabbiano, et al. High-Dose Therapy and Autologous Stem-Cell Transplantation Versus Conventional Therapy for Patients With Advanced Hodgkin's Lymphoma Responding to Front-Line Therapy J. Clin. Oncol., June 15, 2003; 21(12): 2320 - 2325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sieber, H. Tesch, B. Pfistner, U. Rueffer, B. Lathan, O. Brosteanu, U. Paulus, T. Koch, M. Pfreundschuh, M. Loeffler, et al. Rapidly Alternating COPP/ABV/IMEP Is Not Superior to Conventional Alternating COPP/ABVD in Combination With Extended-Field Radiotherapy in Intermediate-Stage Hodgkin's Lymphoma: Final Results of the German Hodgkin's Lymphoma Study Group Trial HD5 J. Clin. Oncol., January 15, 2002; 20(2): 476 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Leoncini, C. Bellan, A. Cossu, P. P. Claudio, S. Lazzi, C. Cinti, G. Cevenini, T. Megha, L. Laurini, P. Luzi, et al. Retinoblastoma-related p107 and pRb2/p130 Proteins in Malignant Lymphomas: Distinct Mechanisms of Cell Growth Control Clin. Cancer Res., December 1, 1999; 5(12): 4065 - 4072. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Gobbi, C. Pieresca, M. L. Ghirardelli, N. DiRenzo, M. Federico, F. Merli, E. Iannitto, V. Pitini, G. Grignani, A. Donelli, et al. Long-Term Results From MOPPEBVCAD Chemotherapy With Optional Limited Radiotherapy in Advanced Hodgkin's Disease Blood, April 15, 1998; 91(8): 2704 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Meyer, I. C. Quirt, J. R. Skillings, M.C. Cripps, V. Bramwell, B. H. Weinerman, M. K. Gospodarowicz, B. F. Burns, A. M. Sargeant, L. E. Shepherd, et al. Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma N. Engl. J. Med., December 9, 1993; 329(24): 1770 - 1776. [Abstract] [Full Text] |
||||
![]() |
J. D. Hainsworth and F. A. Greco Treatment of Patients with Cancer of an Unknown Primary Site N. Engl. J. Med., July 22, 1993; 329(4): 257 - 263. [Full Text] |
||||
![]() |
V. T. DeVita and S. M. Hubbard Hodgkin's Disease N. Engl. J. Med., February 25, 1993; 328(8): 560 - 565. [Full Text] |
||||
![]() |
A. Surbone, J. O. Armitage, and R. P. Gale Autotransplantation in Lymphoma: Better Therapy or Healthier Patients? Ann Intern Med, June 1, 1991; 114(12): 1059 - 1060. [Abstract] [PDF] |
||||
![]() |
B. D. Cheson, L. Lacerna, B. Leyland-Jones, G. Sarosy, and R. E. Wittes Autologous Bone Marrow Transplantation: Current Status and Future Directions Ann Intern Med, January 1, 1989; 110(1): 51 - 65. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||